News Breaks |
|
|
| February 28, 2013 |
| 10:00 EDT |  | SAM, BSFT, RVBD, ADTN, GSK, VSI, OGE, AMAP, UBS, HEI, WLL, STAA, GRPN | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AutoNavi (AMAP) downgraded to Neutral from Buy at Goldman... Groupon (GRPN) downgraded to Market Perform from Outperform at Wells Fargo... HEICO (HEI) downgraded to Neutral from Buy at BofA/Merrill... OGE Energy (OGE) downgraded to Hold from Buy at Jefferies... STAAR Surgical (STAA) downgraded to Market Perform from Outperform at William Blair... Saks (SKS) downgraded to Underweight from Equal Weight at Morgan Stanley... UBS (UBS) downgraded to Market Perform from Outperform at Keefe Bruyette... Vitamin Shoppe (VSI) downgraded to Neutral from Buy at BofA/Merrill... Whiting Petroleum (WLL) downgraded to Neutral from Buy at UBS... BroadSoft (BSFT) downgraded to Market Perform from Outperform at Northland Securities... GlaxoSmithKline (GSK) downgraded to Underweight from Equal Weight at Morgan Stanley... Riverbed (RVBD) downgraded to Neutral from Buy at Sterne Agee... Boston Beer (SAM) downgraded to Hold from Buy at Williams Capital... Adtran (ADTN) downgraded to Equal Weight from Overweight at Stephens... BroadSoft (BSFT) downgraded to Perform from Outperform at Oppenheimer... Groupon (GRPN) downgraded to Underperform from Market Perform at Raymond James. |
|
|
News For AMAP;GRPN;HEI;OGE;STAA;UBS;VSI;WLL;BSFT;GSK;RVBD;SAM;ADTN From The Last 14 Days Check below for free stories on AMAP;GRPN;HEI;OGE;STAA;UBS;VSI;WLL;BSFT;GSK;RVBD;SAM;ADTN the last two weeks. |
|
|
| June 18, 2013 |
| 08:37 EDT |  | GSK | Drug companies turn to microchips to test medicines, WSJ reports
 Subscribe for More Information |
|
| 07:29 EDT |  | UBS | Securities Industry and Financial Markets Association to host a conference
Subscribe for More Information |
|
| 07:14 EDT | | UBS | Ex-UBS trader charged by U.K. in Libor case, Reuters says
Subscribe for More Information |
|
| 07:13 EDT |  | GSK | Aspen in talks buy GSK's Arixtra, Fraxiparine brands
Subscribe for More Information |
|
| 07:07 EDT | | GSK | GlaxoSmithKline receives offer for thrombosis brands from Aspen
GlaxoSmithKline said it received an offer for its thrombosis brands and Notre-Dame de Bondeville site from Aspen Global. A period of exclusivity has been agreed with Aspen. The financial terms are confidential at this time, but the offer includes the transfer of the Arixtra and Fraxiparine brands to Aspen, along with the related manufacturing site and the majority of employees at NDB in France and certain dedicated commercial employees, GSK said. "The proposed transaction is aligned to GSK's strategy of focusing on products with the most growth potential and the delivery of its pipeline," the company added. |
|
| June 17, 2013 |
| 14:20 EDT | | UBS | Criminal charges likely in Libor case, WSJ reports
Subscribe for More Information |
|
| 09:07 EDT | | WLL | Whiting Petroleum to mandatorily convert preferred stock to common stock
Subscribe for More Information |
|
| 07:41 EDT |  | GRPN | Groupon seeing early signs of a turnaround, says Morgan Stanley
Subscribe for More Information |
|
| 06:32 EDT | | STAA | STAAR Surgical gains regulatory approvals for Visian ICL in Korea, Argentina
Subscribe for More Information |
|
| 05:51 EDT | | GRPN | For Groupon, much more work to do, WSJ reports
Groupon (GRPN) was supposed to be at risk of collapse. Bears growled about its gigantic marketing budget and lack of barriers protecting its business. But then the stock surged 12% Friday after Deutsche Bank (DB) published a report recommending investors buy. Now up almost threefold from its all-time low last November, Groupon has clearly put the biggest fears to rest. Yet, at $7.65, Groupon gets too much credit for a return to peppy growth when it still has much work to do, reports the Wall Street Journal's "Heard on the Street."Reference Link |
| |
| June 14, 2013 |
| 12:43 EDT |  | GRPN | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 10:10 EDT |  | GRPN, OGE | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:58 EDT | | GRPN | Groupon rallies after Deutsche ups rating to Buy
Subscribe for More Information |
|
| 09:53 EDT |  | GRPN | Groupon rises after upgrade, price target bump, levels to watch
The shares are up over 11.38% to $7.64 in the pre-market following an upgrade by Deutsche Bank to Buy, with a $10 price target, up from $6. The firm cited its belief that the company can grow billings as well as improved sentiment concerning the company. Next resistance based on current price is at $8.16. Support is at $7.48. |
|
| 09:24 EDT | | GRPN | On The Fly: Pre-market Movers
HIGHER: Groupon (GRPN), up 8% following upgrade at Deutsche Bank... SolarCity (SCTY), up 8% following upgraded to Outperform from Neutral at Credit Suisse... Smith & Wesson (SWHC), up 5.4% after earnings pre-announcement, share buyback plan... Elan (ELN), up 7.7% after starting formal sale process. UP AFTER EARNINGS: Restoration Hardware (RH), up 12.5%. LOWER: China Ming Yang Wind Power (MY), down 4% after CFO steps down... Myriad Genetics (MYGN), down another 4.9% after Supreme Court ruling yesterday on gene patents... News Corp. (NWSA), down 1.5% after CFO announces plan to retire following split. |
|
| 05:47 EDT | | GRPN | Groupon upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information |
|
| 05:41 EDT | | OGE | OGE Energy upgraded to Buy from Hold at Jefferies
Jefferies upgraded OGE Energy on the potential for higher earnings from increased spending at the utility and proposed MLP. The firm raised its priced target for shares to $76 from $74. |
|
| June 13, 2013 |
| 07:09 EDT | | GRPN | Mobile payment companies becoming more competitive, LA Times says
Subscribe for More Information |
|
| June 12, 2013 |
| 19:54 EDT | | GSK | GlaxoSmithKline investigates bribe claims in China, WSJ says
Subscribe for More Information |
|
| 10:14 EDT |  | WLL | On the Fly: Initiation Summary
AMRI (AMRI) coverage resumed with a Buy at Sterne Agee… AMRI (AMRI) re-initiated with a Buy at Sterne Agee… Allscripts (MDRX) re-initiated with a Buy at Sterne Agee… Amkor Technology (AMKR) initiated with a Buy at Sidoti… Astec (ASTE) initiated with a Hold at Stifel… Bob Evans (BOBE) initiated with an Outperform at Oppenheimer… Calumet Specialty Products (CLMT) initiated with an Outperform at Credit Suisse… Cerner (CERN) re-initiated with a Neutral at Sterne Agee… Charles River Labs (CRL) re-initiated with a Buy at Sterne Agee… Covance (CVD) re-initiated with a Buy at Sterne Agee… First Republic Bank (FRC) initiated with an Overweight at Barclays… Greenway Medical (GWAY) re-initiated with an Underperform at Sterne Agee… Gulfport Energy (GPOR) re-initiated with an Outperform at Credit Suisse… ICON plc (ICLR) re-initiated with a Neutral at Sterne Agee… Manitowoc (MTW) initiated with a Buy at Stifel… PAREXEL (PRXL) re-initiated with a Neutral at Sterne Agee… Pacific Drilling (PACD) initiated with an Outperform at Credit Suisse… Perrigo (PRGO) initiated with an Overweight at Morgan Stanley… Quality Systems (QSII) re-initiated with a Neutral at Sterne Agee… Quintiles (Q) initiated with an Underperform at Sterne Agee… Reliance Steel (RS) initiated with a Hold at Topeka… SVB Financial (SIVB) initiated with an Equal Weight at Barclays… Terex (TEX) initiated with a Buy at Stifel… Texas Roadhouse (TXRH) initiated with a Buy at BofA/Merrill… Whiting Petroleum (WLL) initiated with an In-Line at Imperial Capital… athenahealth (ATHN) re-initiated with a Neutral at Sterne Agee. |
| |
|
|
|
|
